Ilsung Is Co., Ltd. (KRX:003120)

South Korea flag South Korea · Delayed Price · Currency is KRW
20,350
-800 (-3.78%)
Last updated: Jan 7, 2026, 12:09 PM KST
20.49%
Market Cap141.47B
Revenue (ttm)66.51B
Net Income (ttm)2.32B
Shares Out6.97M
EPS (ttm)340.76
PE Ratio59.57
Forward PEn/a
Dividend1,000.00 (4.66%)
Ex-Dividend DateDec 29, 2025
Volume5,544
Average Volume6,438
Open21,250
Previous Close21,150
Day's Range20,150 - 21,300
52-Week Range14,500 - 31,450
Beta-0.37
RSI22.36
Earnings DateFeb 26, 2026

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Sector Healthcare
Founded 1954
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.